Candriam S.C.A. - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 134 filers reported holding KURA ONCOLOGY INC in Q2 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$6,305,769
-13.8%
691,4220.0%0.04%
-15.1%
Q2 2023$7,315,245
-20.2%
691,422
-15.1%
0.05%
-17.2%
Q1 2023$9,167,205
-9.3%
814,3640.0%0.06%
-5.9%
Q4 2022$10,105,784
+6.4%
814,364
+17.1%
0.07%
+1.5%
Q3 2022$9,502,000
+18.3%
695,575
+58.7%
0.07%
+1.5%
Q2 2022$8,034,000
+14.0%
438,3150.0%0.07%
+37.5%
Q1 2022$7,047,000
-44.5%
438,315
-51.7%
0.05%
-40.7%
Q4 2021$12,705,000
-28.3%
907,433
-4.1%
0.08%
-32.5%
Q3 2021$17,725,000
-10.2%
946,3570.0%0.12%
-11.1%
Q2 2021$19,732,000
-32.3%
946,357
+1.8%
0.14%
-44.4%
Q1 2021$29,153,000
-3.9%
929,277
-0.0%
0.24%
+1.2%
Q4 2020$30,351,000
+83.7%
929,282
+72.3%
0.24%
+54.8%
Q3 2020$16,521,000
+322.9%
539,196
+124.9%
0.16%
+278.0%
Q2 2020$3,907,000
+86.5%
239,704
+73.6%
0.04%
+46.4%
Q3 2019$2,095,000
-70.5%
138,100
-61.9%
0.03%
-68.5%
Q2 2019$7,098,000
+8.0%
362,100
-8.6%
0.09%
+6.0%
Q1 2019$6,570,000
+27.9%
396,000
+8.2%
0.08%
+6.3%
Q4 2018$5,138,000
-19.8%
366,0000.0%0.08%
-7.1%
Q3 2018$6,405,000
-7.9%
366,000
-4.2%
0.08%
-22.7%
Q2 2018$6,953,000
-3.7%
382,000
-0.8%
0.11%
-10.6%
Q1 2018$7,219,000
-8.4%
385,000
-25.2%
0.12%
-9.6%
Q4 2017$7,880,000
-2.4%
515,000
-4.6%
0.14%
-3.5%
Q3 2017$8,073,000540,0000.14%
Other shareholders
KURA ONCOLOGY INC shareholders Q2 2020
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 3,766,852$57,633,0006.49%
GREAT POINT PARTNERS LLC 2,197,283$33,618,0005.74%
Sio Capital Management, LLC 392,027$5,998,0003.38%
BVF INC/IL 1,353,846$20,714,0002.50%
Boxer Capital, LLC 844,789$12,925,0002.36%
ALETHEA CAPITAL MANAGEMENT, LLC 89,673$1,372,0002.18%
Minerva Advisors LLC 170,921$2,607,0001.41%
NEXTHERA CAPITAL LP 445,550$6,817,0001.26%
DAFNA Capital Management LLC 117,281$1,794,0000.97%
PFM Health Sciences, LP 1,752,124$26,807,0000.64%
View complete list of KURA ONCOLOGY INC shareholders